Folate for Depression

Verdict: A modest add-on, not a standalone treatment

For depression, folate (especially L-methylfolate) shows a small-to-modest benefit only as an add-on to antidepressant medication, not as a standalone treatment. Everyday 400-600 mcg supplements are far below the doses tested and should not be viewed as a depression therapy.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a Preliminary (B) grade because multiple meta-analyses converge on a real but modest add-on effect. Pooled trials found adjunctive L-methylfolate raised antidepressant response rates (RR 1.25 and RR 1.36) and lowered symptom scores (SMD roughly -0.38 to -0.42) versus medication alone (PMID 34794190, 34450256, 38873435). A pivotal double-blind RCT (PMID 23212058) found 15 mg/day effective but 7.5 mg/day non-significant, showing a real yet dose-dependent effect.

It is held at B rather than higher because the quantitative evidence base is small (pooled N around 483-507), confidence intervals for remission sit near unity, several pivotal trials are manufacturer-sponsored, and one major meta-analysis carries a disclosed industry-linked conflict of interest (PMID 34794190). Benefit also concentrates in subgroups such as people with low folate status, MTHFR variants, obesity, or elevated inflammation, limiting how broadly it applies.

Regulators (FDA, WHO, UK NHS) strongly endorse folate, but only for preventing neural-tube defects in pregnancy, not for depression. Clinical sources match the modest tone: the Mayo Clinic notes low folate is associated with depression and suggests discussing folic acid with your doctor, while Cleveland Clinic, Harvard Health, and the specialty consensus all treat it as a recognized but cautious adjunctive option, never a first-line therapy.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.58
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
76%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.40
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L1 ExamineGlobal benchmark
0.70
L2 PubMedPrimary literature
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.577
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders
PMID: 34794190 2022 統合分析 n = 6,707
Finding: Qualitative assessment of 9 articles (N=6,707). Meta-analysis of 3 studies (N=483) showed adjunctive L-methylfolate associated with a small effect on categorical response versus antidepressant monotherapy (RR 1.25, 95% CI 1.08 to 1.46, p=0.004); 4 studies (N=507) showed a continuous-measure effect (SMD -0.38, 95% CI -0.59 to -0.17, p=0.0003).
⚠️ Industry-funded Effect size: RR 1.25 (95% CI 1.08-1.46); SMD -0.38 (95% CI -0.59 to -0.17)
View on PubMed
Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis
PMID: 34450256 2021 統合分析
Finding: 6 RCTs identified, 5 pooled. Adjunct folate produced lower depression scores (MD -2.16, 95% CI -3.62 to -0.69, p=0.004), higher response rate (RR 1.36, 95% CI 1.16-1.59, p=0.0001) and higher remission rate (RR 1.39, 95% CI 1.00-1.92, p=0.05) versus SSRI/SNRI monotherapy.
Effect size: MD -2.16 points; RR response 1.36; RR remission 1.39
View on PubMed
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials
PMID: 23212058 2012 RCT (double-blind) n = 223
Finding: Trial 1 (148 patients, 7.5-15 mg) showed no significant group differences. Trial 2 (75 patients, 15 mg/day) showed adjunctive L-methylfolate significantly more effective than SSRI plus placebo on both primary outcomes; number needed to treat approximately 6. These are the pivotal trials underpinning the 15 mg/day adjunctive dose.
⚠️ Industry-funded Effect size: NNT approximately 6 (Trial 2, 15 mg/day); Trial 1 non-significant
View on PubMed
Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses
PMID: 38873435 2024 Umbrella Review
Finding: 11 meta-analyses included, 8 pooled (5 of RCTs, 3 of observational studies). Folate supplementation significantly reduced depressive symptoms (SMD -0.42, 95% CI -0.57 to -0.27, p<0.001; WMD -3.20, 95% CI -4.00 to -2.41); low serum folate raised depression odds 35% (OR 1.35). Effect greater with supplementation over 10 weeks.
Academic Effect size: SMD -0.42 (95% CI -0.57 to -0.27); WMD -3.20 points
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Health claims relating folate to risk of neural tube defects may be made on the label or in labeling of foods, including dietary supplements, provided that the requirements in this section are met. source↗
L4b EU EFSA
Supportive
L4c UK NHS
Neutral
It's recommended that all women who could get pregnant should take a 400 microgram folic acid supplement daily before pregnancy and until they're 12 weeks pregnant. source↗
L4d TW TFDA / 衛福部
Supportive
孕期缺乏葉酸,會增加胎兒腦及脊髓先天性神經管缺陷的風險。育齡婦女及準備懷孕婦女可在準備階段每日攝取400微克,懷孕期間每日攝取600微克。 source↗
L4e WHO
Neutral
Current evidence suggests that folic acid supplementation in the periconceptional period, either alone or in combination with other vitamins and minerals, can prevent neural tube defects. source↗
L5a NIH Office of Dietary Supplements
Supportive
L5b Mayo Clinic
Cautious
A low level of folate has been associated with depression. If you have depression, it may be worth talking to your doctor about folic acid as a supplement. source↗
L5c Cleveland Clinic
Cautious
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-depression-INT-folate-001 繁體中文版 →